TrialBreast cancer research and treatment2013

Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis.

Joyce O'Shaughnessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.